Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
Supply Chain Experts Discuss the Future of the U.S. Pharmaceutical Cold Chain
HDA hosted a LinkedIn Live event exploring the challenges, successes and future of the U.S. pharmaceutical cold chain. The event delved into key findings from the HDA Research Foundation’s report, The Future of the U.S. Pharmaceutical Cold Chain, and featured perspectives from Jeffrey Gainer, Business Process Senior Manager at McKesson, and Rena K. Goins, Executive Director of Global Trade and Distribution at Regeneron. HDA’s Perry Fri, EVP of Industry Relations and Member Services and COO of the HDA Research Foundation, moderated the discussion. Here are three takeaways from the discussion.
HDA’s 2023 DMA Winners Discuss DSCSA Credentialing and the Value of Collaboration
With the Drug Supply Chain Security Act (DSCSA) implementation deadline on the horizon, HDA members and industry partners are driving innovative solutions to support trading partner compliance. One of the notable examples of this collaboration is demonstrated by HDA’s 2023 Distribution Management Award (DMA) recipients, Spherity and Legisym.
We spoke with Georg Jürgens, Spherity’s Manager of Industry Solutions, and David Kessler, President and Partner of Legisym, about their companies’ histories, award-winning DSCSA solution and collaboration driving innovation within the healthcare distribution supply chain.
Standard Pharmaceutical Product and Medical Device Information (Rx Product Only)
With member input, HDA has developed a standardized format for the information about new pharmaceutical and medical device products.
HDA Statement on Rx Supply Chain Response to Hurricanes Helene And Milton
HDA released a statement regarding the pharmaceutical supply chain’s response to Hurricanes Helene and Milton.